Group One Trading
RLAY icon

Group One Trading’s Relay Therapeutics RLAY Stock Holding History

Group One Trading’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$580K Buy
31,000
+29,300
+1,724% +$425K ﹤0.01% 3354
2026
Q1 		$16.9K Buy
+1,700
New +$15.2K ﹤0.01% 6066
2025
Q4 		– Sell
-21,100
Closed -$110K – 9005
2025
Q3 		$110K Buy
21,100
+20,300
+2,538% +$77.4K ﹤0.01% 5250
2025
Q2 		$2.77K Buy
+800
New +$2.38K ﹤0.01% 7305
2024
Q4 		– Sell
-4,300
Closed -$30.4K – 7856
2024
Q3 		$30.4K Buy
+4,300
New +$32.1K ﹤0.01% 4985
2024
Q2 		– Sell
-10,000
Closed -$83K – 7370
2024
Q1 		$83K Buy
10,000
+8,500
+567% +$82.9K ﹤0.01% 4305
2023
Q4 		$16.5K Hold
1,500
– – ﹤0.01% 5887
2023
Q3 		$12.6K Sell
1,500
-400
-21% -$4.3K ﹤0.01% 6206
2023
Q2 		$23.9K Buy
1,900
+800
+73% +$9.95K ﹤0.01% 5859
2023
Q1 		$18.1K Buy
+1,100
New +$19.7K ﹤0.01% 5576
2022
Q4 		– Sell
-100
Closed -$22K – 7962
2022
Q3 		$22K Buy
+100
New +$2.19K ﹤0.01% 6015

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Group One Trading's RLAY Position: Q2 2026 in Review

Group One Trading sold out of Relay Therapeutics (RLAY) in Q2 2026, closing a stake of 6,638 shares — an estimated $96.4K sold.

Group One Trading first reported a position in RLAY in Q1 2023 and held it in 10 quarters. The position peaked at $245K in Q4 2025. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Group One Trading reported no remaining Relay Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 6,638 Relay Therapeutics shares in Q2 2026, an estimated $96.4K.
  • Group One Trading first reported a position in Relay Therapeutics in Q1 2023 and held it in 10 quarters.
  • Group One Trading's Relay Therapeutics position peaked at $245K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.